Article
Genotypic analysis of the V3 region of HIV from virologic nonresponders to maraviroc-containing regimens reveals distinct patterns of failure.
Antimicrobial agents and chemotherapy - 1 Dec 2013
Swenson Luke C, Chui Celia K S, Brumme Chanson J, Chan Dennison, Woods Conan K, Mo Theresa, Dong Winnie, Chapman Doug, Lewis Marilyn, Demarest James F, James Ian, Portsmouth Simon, Goodrich James, Heera Jayvant, Valdez Hernan, Harrigan P Richard
Abstract excerpt
Changes in HIV tropism from R5 to non-R5 or development of drug resistance is often associated with virologic failure in patients treated with maraviroc, a CCR5 antagonist. We sought to examine changes in HIV envelope sequences and inferred tropism in patients who did not respond to maraviroc-based regimens. We selected 181 patients who experienced early virologic failure on maraviroc-containing therapy in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
